drugset / Trial / NCT07656350
Challenging the Endocannabinoid System in Sleep Restricted Healthy Volunteers to Modulate Physiological Arousal (CANISLEEP) Study
Recruiting
60 enrolled
King's College London
South London and Maudsley NHS Foundation Trust · collab
RandomizedParallel-groupQuadruple-blindBasic science
Summary
The goal of this study is to learn about the body's response to cannabis based products in sleep deprived people who are currently experiencing anxiety but are otherwise healthy.
Timeline
- Start
- 2026-06-02
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cannabidiol | Other / unclassified | 300 mg | — |
| Subject | Dronabinol | Other / unclassified | 2.5 mg | — |
Indications
No indication recorded.